Pazopanib-d6
|
- $290 - $710
- Product name: Pazopanib-d6
- CAS: 1219592-01-4
- MF: C21H23N7O2S
- MW: 437.52
- EINECS:
- MDL Number:
- Synonyms:Pazopanib-d6;2-methyl-5-[[4-[methyl-d3-[3-methyl-2-(methyl-d3)-2H-indazol-6-yl]amino]-2-pyrimidinyl]amino]-benzenesulfonamide;2H6]-Pazopanib
3 prices
Selected condition：
Brand
- AK Scientific
- Cayman Chemical
Package
- 500μg
- 1mg
- ManufacturerAK Scientific
- Product number3396DH
- Product description2-Methyl-5-[[4-[[3-methyl-2-(trideuteriomethyl)indazol-6-yl]-(trideuteriomethyl)amino]pyrimidin-2-yl]amino]benzenesulfonamide
- Packaging1mg
- Price$710
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number25446
- Product descriptionPazopanib-d6 ≥99% deuterated forms (d1-d6)
- Packaging500μg
- Price$290
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number25446
- Product descriptionPazopanib-d6 ≥99% deuterated forms (d1-d6)
- Packaging1mg
- Price$549
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 3396DH | 2-Methyl-5-[[4-[[3-methyl-2-(trideuteriomethyl)indazol-6-yl]-(trideuteriomethyl)amino]pyrimidin-2-yl]amino]benzenesulfonamide | 1mg | $710 | 2021-12-16 | Buy |
| Cayman Chemical | 25446 | Pazopanib-d6 ≥99% deuterated forms (d1-d6) | 500μg | $290 | 2024-03-01 | Buy |
| Cayman Chemical | 25446 | Pazopanib-d6 ≥99% deuterated forms (d1-d6) | 1mg | $549 | 2024-03-01 | Buy |
Properties
storage temp. :Store at -20°C
solubility :DMF: 16 mg/ml; DMSO: 16 mg/ml
form :A solid
solubility :DMF: 16 mg/ml; DMSO: 16 mg/ml
form :A solid
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
Pazopanib-d6 is intended for use as an internal standard for the quantification of pazopanib by GC- or LC-MS. Pazopanib is a multi-kinase inhibitor that inhibits the VEGF receptors VEGFR1, VEGFR2, and VEGFR3 (IC50s = 10, 30, and 47 nM, respectively, in a cell-free enzyme assay).1 It also inhibits PDGFRα, PDGFRβ, and c-Kit (IC50s = 71, 84, and 74 nM, respectively, in a cell-free enzyme assay) as well as additional receptor tyrosine kinases. Pazopanib inhibits upregulation of the surface adhesion proteins ICAM-1 and VCAM-1 induced by VEGF in multiple myeloma cells cocultured with human umbilical vein endothelial cells (HUVECs) and decreases multiple myeloma cell adhesion to HUVECs.2 It also inhibits proliferation of multiple myeloma cells cocultured with HUVECs. Pazopanib (30 and 100 mg/kg) reduces tumor growth, induces apoptosis, decreases angiogenesis, and increases survival in a multiple myeloma mouse xenograft model. Formulations containing pazopanib have been used in the treatment of cancer.More related product prices
444731-75-3 N-(2-chloropyriMidin-4-yl)-2,3-diMethyl-2H- indazol-6-aMine 3-AMINO-4-METHYLBENZENESULFONAMIDE 1,3-DiMethyl-6-aMino-1H-indazole 5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide 2-Methyl-5-nitrobenzenesulfonamide 2,3-DIMETHYL-6-NITRO-2H-INDAZOLE Pazopanib 2(1H)-Pyrimidinone, 4-chloro- (6CI,9CI) 4(1H)-Pyrimidinone, 2-chloro- (9CI) 2,3-dimethyl-2H-indazol-6-amine hydrochloride 3-Methyl-6-nitroindazole 20191-74-6 6973-09-7 3-Methyl-1H-indazol-6-ylamine ,97% 5-Amino-2,3-dimethyl-2H-indazole 2,4-Dichloropyrimidine 6-NitroindazoleRelated product price
- 444731-75-3
$49-8639.4 - N-(2-chloropyriMidin-4-yl)-2,3-diMethyl-2H- indazol-6-aMine
$11-975 - 3-AMINO-4-METHYLBENZENESULFONAMIDE
$50-1504.9
Suppliers and manufacturers
ChemStrong Scientific Co.,Ltd
Shanghai Hongye Biotechnology Co. Ltd
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Guangzhou Juntang Technology Co., Ltd
Shanghai YuZn Pharm. Technology Co.,Ltd.
LGC Science (Shanghai) Ltd.
Shanghai Yifei Biotechnology Co. , Ltd.
Nanjing Shizhou Biology Technology Co.,Ltd
Shanghai Aitixi Biotechnology Co., Ltd
Nantong Hanfang Biotechnology Co. , Ltd.